Abbott Laboratories (ABT) Dividends payables Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.55% |
| Dec 31, 2025 | 6.57% |
| Sep 30, 2025 | 10.02% |
| Jun 30, 2025 | 10.09% |
| Mar 31, 2025 | 10.13% |
| Dec 31, 2024 | 10.03% |
| Sep 30, 2024 | 11.01% |
| Jun 30, 2024 | 11.12% |
| Mar 31, 2024 | 11.12% |
| Dec 31, 2023 | 11.15% |
| Sep 30, 2023 | 12.44% |
| Jun 30, 2023 | 12.48% |
| Mar 31, 2023 | 12.54% |
| Dec 31, 2022 | 12.65% |
| Sep 30, 2022 | 12.16% |
| Jun 30, 2022 | 12.32% |
| Mar 31, 2022 | 12.32% |
| Dec 31, 2021 | 16.27% |
| Sep 30, 2021 | 15.72% |
| Jun 30, 2021 | 15.84% |
| Mar 31, 2021 | 15.96% |
| Dec 31, 2020 | 15.81% |
| Sep 30, 2020 | 12.22% |
| Jun 30, 2020 | 12.22% |
| Mar 31, 2020 | 12.22% |
| Dec 31, 2019 | 11.90% |
| Sep 30, 2019 | 11.30% |
| Jun 30, 2019 | 11.33% |
| Mar 31, 2019 | 11.33% |
| Dec 31, 2018 | 10.55% |
| Sep 30, 2018 | 17.84% |
| Jun 30, 2018 | 17.67% |
| Mar 31, 2018 | 17.59% |
| Dec 31, 2017 | 17.22% |
| Sep 30, 2017 | -10.58% |
| Jun 30, 2017 | -10.45% |
| Mar 31, 2017 | -10.50% |
| Dec 31, 2016 | -12.31% |
| Sep 30, 2016 | -12.48% |
| Jun 30, 2016 | -12.51% |
| Mar 31, 2016 | -12.53% |
| Dec 31, 2015 | -10.87% |
| Dec 31, 2014 | -10.22% |